Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK‐432 for resectable pancreatic cancer patients
Hisahito Endo(Fukushima Medical University), Mitsukazu Gotoh(Osaka Prefectural Medical Center), Masanori Terashima(Shizuoka Cancer Center), Takayuki Anazawa(Fukushima Medical University), Hiromasa Ohira(Fukushima Medical University), Tetsu Sato(Fukushima Medical University), Akira Kenjo(Fukushima Medical University), Mika Hoshino(Fukushima Medical University), Takuto Hikichi(Fukushima Medical University Hospital), Takashi Kimura(Fukushima Medical University), Takuro Saito(Osaka International Cancer Institute), Atsushi Irisawa(Dokkyo Medical University), Tadayuki Takagi(Fukushima Medical University)
Cited by 50
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
|Nature Communications|2016|210
Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011‐2017
|Annals of Gastroenterological Surgery|2019|210